You searched for "vascular"
ILM peeling in primary rhegmatogenous retinal detachment
1 June 2015
| Saruban Pasu
|
EYE - Vitreo-Retinal
This author retrospectively analysed the correlation between internal limiting membrane (ILM) peeling and the occurrence of a postoperative epiretinal membrane (ERM) in patients who underwent vitrectomy for rhegmatogenous retinal detachment (RD). There were 135 medical records investigated. Seventy patients underwent...
ABCA1 mediates lipid efflux in the retina
1 June 2018
| Graham Wallace
|
EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is the leading cause of blindness in the elderly population. There are two forms of AMD, dry and wet, the latter so named because of the presence of choroidal neovascularisation. Both forms lead to retinal pigment...
Ametropic amblyopia and stereopsis
This study aimed to evaluate the correlations between ametropic amblyopia (hypermetropic – 110, myopic – 30, and astigmatic – 65) and stereopsis in 205 children – mean age of 5.2 years ±1.8. For near stereopsis, significant results were found for...Methotrexate and mycophenolate mofetil for non-infectious uveitis
1 February 2015
| Brian Ang
|
EYE - Vitreo-Retinal
This is the first reported randomised clinical trial comparing methotrexate versus mycophenolate mofetil (MMF) for the treatment of non-infectious intermediate uveitis, posterior uveitis or panuveitis. To be eligible for recruitment, patients had to be on ≥15mg oral prednisone and demonstrated...
Resolution of mid-peripheral schisis in x-linked retinoschisis with the use of dorzolamide
1 October 2014
| Huw Edward Oliphant
|
EYE - Vitreo-Retinal
X-linked retinoschisis (XLRS) is an early onset hereditary retinal dystrophy. It is caused by mutations of the RS1 gene. Common manifestations of XLRS are schitic lesions at the macula, as well as infero-temporal schisis. Carbonic anhydrase inhibitors have previously been...
Gender variations in retinopathy
1 August 2014
| Nana Theodorou
|
EYE - Vitreo-Retinal
The Tromso Eye Study is a substudy of the Tromso Study; a population based longitudinal study based in Norway. The extensive 5869 participants had no diabetes and were aged between 30-87 years. Retinal images from both eyes were taken using...
Complement Factor H and Factor H-Like protein are expressed in human RPE cells
1 April 2014
| Bheemanagouda Patil
|
EYE - General
The role of inflammation in age-related macular degeneration (AMD) is well documented and the association of AMD with the inflammatory marker C-reactive protein (CRP) and members of the complement system underline the role of complements in AMD. Human complement factor...
Smoking and Behçet’s disease
1 October 2015
| Saruban Pasu
|
EYE - Vitreo-Retinal
This study aimed to investigate the relationship between smoking and prognosis of ocular Behçet’s disease (BD). Records of 202 patients with ocular features of BD were reviewed from a Turkish hospital. Patients were divided into two groups according to their...
Microperimetry of subretinal drusenoid deposits
1 February 2014
| Bheemanagouda Patil
|
EYE - Vitreo-Retinal
Subretinal drusenoid deposits (SDD), originally termed ‘reticular pseudo-drusen’, have recently been identified by histology and optical coherence tomography (OCT) as aggregations located in the subretinal rather than the sub retinal pigment epithelium (RPE) space. These deposits affect the amount of...
HtrA1 enhances cell senescence
1 December 2013
| Graham Wallace
|
EYE - Vitreo-Retinal
A genetic basis for age-related macular degeneration (AMD) has been greatly advanced in recent years. The role of identified pathways such as complement factor H in AMD has been widely investigated. However, the effect of other gene variants identified by...
Diclofenac versus Bromfenac after cataract surgery
1 April 2019
| Kurt Spiteri Cornish
|
EYE - Cataract, EYE - Refractive
|
Non-steroidal anti-inflammatory drugs, bromfenac, cataract surgery, diclofenac, intraocular inflammation
Non-steroidal anti-inflammatory drugs (NSAIDs) are commonly used after cataract surgery to reduce inflammation and cystoid macular oedema (CMO). Diclofenac 0.1% is used three to five times daily for 28 days and Bromfenac 0.09% twice daily for 14 days postoperatively. The...
IOL tilt with air tamponade vs. salt solution
1 October 2019
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this study the authors made a comparison of significant postoperative tilt of IOL with air tamponade as opposed to balanced salt solution, in the procedure of combined phaco with IOL and vitrectomy. Thirty-four patients were included into the analysis....